Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 25/03/2013 19392_de.jpg

    SHENC – shear flow regulation of hemostasis

    The first step in closing wounds is the aggregation of the von Willebrand factor glycoprotein with blood platelets, which plugs the hole in the blood vessel and stops blood from leaking out. Using computer simulations and artificial blood vessel experiments, researchers from Mannheim have shown that this aggregation is a reversible process that depends on the shear forces resulting from the flow of the blood. This also prevents the clogging of…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/shenc-shear-flow-regulation-of-hemostasis
  • Article - 11/02/2010 10687_de.jpg

    Johanna Schanz: Liver model as an alternative to animal experiments

    Blood vessels of a piece of pig’s intestine are used as carrier material for the IGB’s liver model and the cells seeded on the blood vessels stem from human biopsies. Dr. Johanna Schanz from the Fraunhofer IGB used this combination to produce her doctoral thesis which led to impressive results: a functional system of blood vessels in a biological carrier structure. Schanz’s outstanding thesis results have led to the creation of a liver model for…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/johanna-schanz-liver-model-as-an-alternative-to-animal-experiments
  • Article - 19/05/2009 Immunofluorescent staining reveals a growing artery (cross section, stained green). The dividing nuclei of smooth muscle cells are stained green.

    What makes blood vessels sprout?

    Calcified arteries or capillaries – this is often associated with blood stasis, reduced oxygen supply, and subsequent cardiac strain that compensates these deficiencies. Dr. Sebastian Grundmann from the Department of Cardiology and Angiology at the University Medical Centre Freiburg and his team are investigating how the growth of blood vessels is triggered, and potentially find ways to naturally deviate the site of congestion.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/what-makes-blood-vessels-sprout
  • Article - 15/03/2008

    Mannheim as a stroke research centre

    Neurologists at the University Hospital of Mannheim are the central points of contact of the largest European stroke project to date. The European Union is providing more than 21 million euros over five years for research focusing on stroke.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/mannheim-as-a-stroke-research-centre
  • Article - 21/04/2008

    Human blood system in mice

    Scientists from Mannheim Heidelberg an Freiburg working together in the cooperative research area Vascular Biology have developed a method that can be used to create a human vascular system in mice which stays functional even after several months.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/human-blood-system-in-mice
  • Article - 22/09/2009 Portrait of the Deputy Director of the Ulm-based ILM, Alwin Kienle, who is responsible for the ILM's research.<br />

    Alwin Kienle: an eye for the whole picture

    Harvest time has now come for physicist Alwin Kienle. In the next year or two the results of his basic research will result in the establishment of an applied centre focusing on the determination of the optical characteristics of scattering media. The deputy director of the Ulm-based ILM hopes that the new optical competence centre will lead to attractive solutions for the pharmaceutical medical device and nutrition sectors.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/alwin-kienle-an-eye-for-the-whole-picture
  • Press release - 08/09/2009 The photo shows a chicken egg model used to examine vascularistion in tissue engineering.

    Angiogenesis as a key for tissue engineering

    The German Research Foundation is to fund a research priority of the Department of Plastic Surgery at the Freiburg University Medical Centre. Researchers around the world working in the area of regenerative medicine are all equally hopeful of generating tissue replacements using modern tissue engineering. The development of tissue cells on carrier materials seems quite promising. However, tissue-engineered implants are often rejected by patients…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/angiogenesis-as-a-key-for-tissue-engineering
  • Company profile - 05/07/2016 Logo_final.jpg

    HS-Analysis GmbH – using digital histology to develop new drugs

    The idea of analysing tissue samples automatically sounds more of a pipe dream than anything else. However, it already happens. HS-Analysis GmbH's ability to interpret tissue samples automatically is driving new drug development a decisive step forward.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/hs-analysis-gmbh-using-digital-histology-to-develop-new-drugs
  • Press release - 30/09/2011 15269_de.jpg

    Blood Vessels from Your Printer

    Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
  • Article - 27/04/2009 Paradigm change in angiogenesis research

    Interaction mechanisms between tumours and blood vessels

    In recognition of the growing importance of angiogenesis research in the field of oncology the German Research Foundation has established two new research consortia as part of its Angiogenesis research priority programme one project focuses on the mechanisms of vascular differentiation and the second on the interaction between tumour cells and cells of the vascular wall which are prerequisites for tumour growth and metastasis.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/interaction-mechanisms-between-tumours-and-blood-vessels
  • Article - 05/04/2009 08322_de.jpg

    JOTEC – artificial blood vessel specialist

    JOTEC GmbH a medical device company based in Hechingen has a broad range of solutions on offer for the therapy of vascular diseases including artificial blood vessels and stentgrafts and is an international leader in this field. The company not only produces traditional vascular grafts from high-quality plastics but also absorbable bioartificial vascular grafts and cell-coated grafts made from biomaterials. Such an approach is currently unique in…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/jotec-artificial-blood-vessel-specialist
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Press release - 23/07/2020

    Images from the inside of blood vessels

    Smallest 3D printed miniature endoscope in the world detects cholesterol plaques and thrombs inside human and mouse arteries.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/3d-bilder-aus-dem-inneren-von-adern
  • Article - 07/07/2010 Different aspects of the functional and phenotypic regulation of the cells of the vessel wall are studied by the project group A-C of the SFB-TR23.

    Excellent vascular research in Baden-Württemberg

    The fact that the DFG are continuing to fund the only collaborative research centre (SFB, Sonderforschungsbereich) in Germany that is exclusively focused on vascular research underlines the concentrated expertise found in Mannheim and Heidelberg in the field of vascular biology.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/excellent-vascular-research-in-baden-wuerttemberg
  • Article - 23/04/2012 16957_de.jpg

    Vascular grafts: biomolecules to prevent blood vessels from reclosing

    Obstructed blood vessels can be operated on and adequate blood flow restored. However, stents and bypasses are often subject to high reclosure rates. Excessive immune reactions close to where the intervention took place might prevent the regeneration of adjacent vessel walls and even lead to reclosure. New interventions involving RNA interference seem to be a way out of this dilemma.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/vascular-grafts-biomolecules-to-prevent-blood-vessels-from-reclosing
  • Article - 09/05/2016 The schematic on the left shows the concept: an implantable single-use probe head, coupled to a telemetry unit close to the patient's bed by way of a plug and a cord. The telemetry unit is shown as a small rectangular box from which enables wireless transfer of the recorded data to the hospital computer network. The schematic on the right shows details of the plug connection.

    FlexiTel – microsensors for tissue monitoring

    When soft tissue is transplanted, for example in a patient undergoing tumour surgery, care must be taken to ensure that the new tissue is connected to the blood system in the area where the tumour has been removed. How well this works is difficult to find out, especially in the case of deep-seated defects. Partially implantable microsensor probes called FlexiTel have the potential to improve this situation by monitoring success during the first…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/flexitel-microsensors-for-tissue-monitoring
  • Article - 23/04/2009 08468_de.jpg

    Cancer therapy targets angiogenesis

    The idea of starving tumours by interrupting their blood supply has despite initial drawbacks generated the production of blockbuster drugs and is now a major RD focus for biotechnology and pharmaceutical companies. But the biological effects are more complicated than originally expected.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/cancer-therapy-targets-angiogenesis
  • Press release - 25/06/2010 11612_de.jpg

    Von-Langenbeck Prize awarded for the first time to regenerative medicine methods

    In 2010 the Von-Langenbeck Prize was awarded to Dr. Thorsten Walles from the Schillerhöhe Hospital in Stuttgart. In cooperation with his partners Walles has developed an innovative method for regenerative medicine applications which involves the generation of tissue from the patients own cells to replace defective air pipes and oesophagus. The prize was awarded for the first time ever to a medical doctor in recognition of the development and…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/von-langenbeck-prize-awarded-for-the-first-time-to-regenerative-medicine-methods
  • Press release - 16/04/2008

    Effective Cancer Immune Therapy Through Order in the Blood Vessels

    Researchers at the German Cancer Research Center have discovered a key molecule that is responsible for the immature structure of blood vessels in malignant tumors. If this molecule is switched off in mice vessels normalize so that immune cells are better able to get to the tumor tissue.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/effective-cancer-immune-therapy-through-order-in-the-blood-vessels
  • Press release - 06/01/2008

    Heart catheter examinations - an elegant method with huge potential

    The method is elegant and cardiologists love it heart catheter examination. The number of catheter examinations carried out has continuously increased over the last few years. In 2005 in Germany an impressive number of 772000 heart catheter examinations were carried out.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/heart-catheter-examinations-an-elegant-method-with-huge-potential
  • Article - 18/08/2014 The photo shows 7 staff members of VAXIMM GmbH.

    VAXIMM: Vaccines that impede cancer growth

    VAXIMM GmbH, a young biotechnology company from Mannheim, Germany, specialises in the development of vaccines for cancer treatment. The company’s first product candidate, VXM01, is a live oral vaccine that targets the VEGFR-2 receptor and hence the blood supply of tumours. VXM01 is currently undergoing clinical testing in pancreatic cancer patients.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/vaximm-vaccines-that-impede-cancer-growth
  • Press release - 24/01/2017

    Cancer Medications Learn to Hide

    The European Research Council awards Wilfried Weber an ERC Proof of Concept Grant. Wilfried Weber, Professor of Synthetic Biology at the University of Freiburg, has received a grant of roughly €150,000 for his project “Hide and Seek with Cancer Drugs” in which he is working to improve the drugs used in cancer treatment.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-medications-learn-to-hide
  • Article - 15/04/2010 11188_de.jpg

    Molecular biomechanics or mechanobiochemistry

    Frauke Gräter is head of the Molecular Biomechanics research group at the Institute for Theoretical Studies in Heidelberg. Gräter uses computer-based methods to investigate the mechanical forces acting on biological macromolecules in the nanometre range. Her team was also able to show that highly complex processes such as haemostasis are regulated by shear forces.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/molecular-biomechanics-or-mechanobiochemistry
  • Press release - 02/06/2010 11352_de.jpg

    Hohenstein researchers make progress on biotolerance of textile implants

    The capacity of a textile implant to be tolerated by the body – known as biotolerance – plays an important role in regenerative medicine. Nevertheless, the body does not always tolerate textile implants. Even modern implants made of resorbable biopolymers, such as polylactic acid, break down in the body after a certain period of time and decompose into individual acidic components.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/hohenstein-researchers-make-progress-on-biotolerance-of-textile-implants
  • Article - 04/03/2013 Diagram showing how CARL® works: the drug is distributed in the body and part of it is removed with two filters.

    TellTargeting Medical GmbH – targeted chemotherapy using CARL®

    The needs of cancer patients are clear chemotherapies that are as gentle as possible associated with minimal adverse effects and have a rapid effect. This is often difficult to achieve because the drug that stops tumour growth needs to remain in the body for a certain amount of time during which time it damages cancerous as well as healthy structures. Dr. Gerhard Pütz and Dr. Jürgen Eckes founded the company TellTargeting Medical GmbH Co. KG…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/telltargeting-medical-gmbh-targeted-chemotherapy-using-carl

Page 1 / 4

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search